{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5f2442bc6de29f32c4d05451/69b83a8f63444515f9ccb400?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The BRAIN miniseries | Exploring the neuropathogenesis of HIV and mentoring the next generation of scientists","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5f2442bc6de29f32c4d05451/1773681039687-4fdd2103-ce5a-4ad2-8009-993a0b79eecc.jpeg?height=200","description":"<p><strong>In our third episode of the BRAIN (Black Researchers Addressing Inequalities in Neuroscience) podcast miniseries, we're exploring the research being done at the intersection of neuroscience, immunology and pharmacology to investigate HIV.&nbsp;</strong></p><p><br></p><p>Our guest is Dionna Williams, an Associate Professor at Emory University whose research centers on the neuropharmacology and neuroimmunology of HIV, identifying mechanisms by which HIV antiretroviral therapies cross the blood-brain barrier, the capacity of the brain as a drug-metabolizing organ, and the impact of substance use on treating the brain during HIV. Dionna's group is also evaluating whether cannabinoids can be used to modulate immune responses to HIV and restore neurologic health. Furthermore, Dionna incorporates studies evaluating biologic contributors that perpetuate HIV health disparities into their research program. Beyond research, Dionna is passionate about supporting trainees from marginalized groups in their scientific journeys.</p>","author_name":"BioTechniques"}